
From carve-out to pan-European platform with CNX Therapeutics
Most pharma businesses are built on new drugs. CNX Therapeutics was built on the ones big pharma had overlooked. Carved out of US group Sunovion in 2021 with a single product, it now spans more than 60 countries, has gro














